Page last updated: 2024-09-05

organophosphonates and Carcinoma, Anaplastic

organophosphonates has been researched along with Carcinoma, Anaplastic in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (20.00)	18.7374
1990's	5 (25.00)	18.2507
2000's	7 (35.00)	29.6817
2010's	4 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akst, L; Best, SR; Bishop, JA; Hillel, A; Karatayli-Ozgursoy, S	1
Abbattista, MR; Ackerley, DF; Anderson, RF; Ashoorzadeh, A; Bull, MR; Copp, JN; Flanagan, JU; Guise, CP; Mowday, AM; Patterson, AV; Silva, S; Smaill, JB; Williams, EM	1
Banerjee, S; Das, T; Kamaleshwaran, KK; Shinto, A	1
Dikkers, FG	1
Andrei, G; De Schutter, T; Duraffour, S; Matthys, P; Mitera, T; Naesens, L; Snoeck, R; Topalis, D; van den Oord, J	1
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D	1
Pagano, JS; Raab-Traub, N; Wakisaka, N; Yoshizaki, T	1
Snoeck, R	1
Barnett, BL; Deprèle, S; Ebetino, FH; Evdokimov, A; Hogan, JM; Kashemirov, BA; McKenna, CE	1
Holý, A; Kren, V; Krenová, D; Otová, B; Votruba, I; Zídek, Z	1
Burch, PA; Kovach, JS; Marschke, RF; O'Connell, MJ; Rubin, J; Schutt, AJ; Wieand, HS	1
Asbury, RF; Blessing, JA; Clarke-Pearson, D; Homesley, HD; Look, KY	1
Asbury, R; Blessing, JA; Buller, R; Look, KY; Lucci, JA	1
De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R	1
Murono, S; Pagano, JS; Raab-Traub, N	1
Abdulkarim, B; Bourhis, J; Chagraoui, H; Chouaïb, S; Deutsch, E; Eschwege, F; Maggiorella, L; Sabri, S; Thierry, J; Vainchenker, W	1
Boorman, GA; Cardy, RH; Dunnick, JK; Haseman, JK; Langloss, J; Manus, AG	1
Henkin, RE; Quinn, JL; Thrupkaew, AK	1
Raskin, MM; Serafini, AN; Watson, DD; Zand, LC	1
Cochran, AJ; Watson, AA	1

Reviews

1 review(s) available for organophosphonates and Carcinoma, Anaplastic

Article	Year
Papillomavirus and treatment. Antiviral research, 2006, Volume: 71, Issue:2-3 Topics: Antiviral Agents; Carcinoma; Chemotherapy, Adjuvant; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines; Warts	2006

Trials

3 trial(s) available for organophosphonates and Carcinoma, Anaplastic

Article	Year
Advanced colorectal adenocarcinoma: treatment with amonafide. Journal of the National Cancer Institute, 1994, Jun-15, Volume: 86, Issue:12 Topics: Adenine; Antineoplastic Agents; Carcinoma; Colorectal Neoplasms; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Organophosphonates	1994
A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer. American journal of clinical oncology, 1993, Volume: 16, Issue:6 Topics: Adenine; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Ovarian Neoplasms	1993
A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. American journal of clinical oncology, 1997, Volume: 20, Issue:6 Topics: Adenine; Adult; Antineoplastic Agents; Carcinoma; Female; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Uterine Cervical Neoplasms	1997

Other Studies

16 other study(ies) available for organophosphonates and Carcinoma, Anaplastic

Article	Year
Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population. The Annals of otology, rhinology, and laryngology, 2016, Volume: 125, Issue:3 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma; Cell Transformation, Neoplastic; Child; Child, Preschool; Cidofovir; Cytosine; Humans; Infant; Middle Aged; Organophosphonates; Papillomavirus Infections; Respiratory Tract Infections; Respiratory Tract Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Smoking; Young Adult	2016
Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy. Biochemical pharmacology, 2016, 09-15, Volume: 116 Topics: 3-Hydroxysteroid Dehydrogenases; Activation, Metabolic; Aldo-Keto Reductase Family 1 Member C3; Animals; Antineoplastic Agents, Alkylating; Benzamides; Carcinoma; Cell Proliferation; Colorectal Neoplasms; Drug Design; Drug Resistance, Neoplasm; Enzyme Inhibitors; Escherichia coli Proteins; HCT116 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Mesylates; Mice, Nude; Models, Molecular; Molecular Docking Simulation; Nitroreductases; Organophosphonates; Prodrugs; Random Allocation; Recombinant Proteins; Specific Pathogen-Free Organisms; Substrate Specificity; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays	2016
170Tm-EDTMP: A Prospective Alternative of 89SrCl2 for Theranostic Treatment of Metastatic Bone Pain. Clinical nuclear medicine, 2017, Volume: 42, Issue:3 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Cancer Pain; Carcinoma; Female; Humans; Organometallic Compounds; Organophosphonates; Radiopharmaceuticals; Thulium	2017
Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma. International journal of pediatric otorhinolaryngology, 2008, Volume: 72, Issue:10 Topics: Animals; Antineoplastic Agents; Carcinogenicity Tests; Carcinoma; Cidofovir; Cytosine; Humans; Infusions, Intralesional; Laryngeal Neoplasms; Organophosphonates; Rats; Teratogens	2008
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice. Cancer letters, 2013, Feb-28, Volume: 329, Issue:2 Topics: Animals; Antineoplastic Agents; Brain; Cachexia; Carcinoma; Cell Line, Tumor; Cidofovir; Cytokines; Cytosine; Female; Human papillomavirus 16; Humans; Kynurenine; Leukocyte Count; Liver; Mice; Mice, Nude; Organophosphonates; Papillomavirus Infections; Spleen; Splenomegaly; Tryptophan; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2013
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene, 2003, Apr-17, Volume: 22, Issue:15 Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays	2003
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts. International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme Inhibitors; Epstein-Barr Virus Infections; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Ribonucleotide Reductases; Transplantation, Heterologous; Tumor Cells, Cultured	2005
Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies. Bioorganic & medicinal chemistry letters, 2008, May-01, Volume: 18, Issue:9 Topics: Algorithms; Binding Sites; Bone Density Conservation Agents; Carcinoma; Computer Simulation; Crystallography, X-Ray; Diphosphonates; Enzyme Inhibitors; Etidronic Acid; Farnesyltranstransferase; Humans; Imidazoles; Inhibitory Concentration 50; Magnesium; Models, Chemical; Organophosphonates; Pyridines; Risedronic Acid; Stereoisomerism; Structure-Activity Relationship; Zoledronic Acid	2008
Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). III. Rat and mouse carcinomas and sarcomas. Folia biologica, 1993, Volume: 39, Issue:6 Topics: Adenine; Animals; Antiviral Agents; Carcinoma; Female; Mice; Mice, Inbred C57BL; Organophosphonates; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sarcoma, Experimental; Tumor Cells, Cultured	1993
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer research, 1998, Feb-01, Volume: 58, Issue:3 Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Assays, Antitumor; Female; Ganciclovir; Genes, p53; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Injections, Intralesional; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Tumor Virus Infections	1998
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. Cancer research, 2001, Nov-01, Volume: 61, Issue:21 Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cidofovir; Cytosine; Epithelial Cells; Growth Inhibitors; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Organophosphorus Compounds; Tenofovir; Xenograft Model Antitumor Assays	2001
Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene, 2002, Apr-04, Volume: 21, Issue:15 Topics: Animals; Antiviral Agents; Carcinoma; Cell Division; Cidofovir; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Radiation-Sensitizing Agents; Radiation, Ionizing; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2002
Lung neoplasms in rodents after chronic administration of dimethyl hydrogen phosphite. Cancer research, 1986, Volume: 46, Issue:1 Topics: Adenoma; Animals; Body Weight; Brain Neoplasms; Carcinogens; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Hyperplasia; Lung Neoplasms; Male; Mice; Organophosphonates; Organophosphorus Compounds; Phosphites; Precancerous Conditions; Rats; Stomach Neoplasms; Testicular Neoplasms	1986
False negative bone scans in disseminated metastatic disease. Radiology, 1974, Volume: 113, Issue:2 Topics: Adenocarcinoma; Aged; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Carcinoma; False Negative Reactions; Female; Fluorine; Humans; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Organophosphonates; Pelvis; Prostatic Neoplasms; Radiography; Radioisotopes; Radionuclide Imaging; Ribs; Technetium; Thoracic Vertebrae	1974
Radionuclide breast scanning in carcinoma of the breast. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1974, Volume: 15, Issue:12 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; False Negative Reactions; False Positive Reactions; Female; Humans; Middle Aged; Organophosphonates; Phosphates; Radionuclide Imaging; Technetium	1974
Liver changes resembling those seen in acute phosphorus poisoning in a patient receiving cytotoxic drugs. Medicine, science, and the law, 1969, Volume: 9, Issue:3 Topics: Aged; Alkylating Agents; Aziridines; Azirines; Carcinoma; Female; Humans; Liver; Organophosphonates; Ovarian Neoplasms; Phosphorus	1969